Clinical Trial Update: Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver [NA]

View source ↗

Summary

A feasibility study evaluating a deep learning-based MDixon Quant tool to quantify chemotherapy-induced fatty liver. The trial is sponsored by Yunnan Cancer Hos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Yunnan Cancer Hospital | Conditions: Non-Alcoholic Fatty Liver Disease | NA | Status: RECRUITING